Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 147.4

(3.08%)

Total Debt Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual total debt in 2023 was 215.18 Million ILS , up 1.13% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly total debt in 2024 Q2 was 206.81 Million ILS , down -1.19% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported annual total debt of 212.77 Million ILS in 2022, up 27.55% from previous year.
Novolog (Pharm-Up 1966) Ltd reported annual total debt of 166.81 Million ILS in 2021, up 8.15% from previous year.
Novolog (Pharm-Up 1966) Ltd reported quarterly total debt of 209.3 Million ILS for 2024 Q1, down -2.73% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported quarterly total debt of 203 Million ILS for 2023 Q3, down -2.14% from previous quarter.

Annual Total Debt Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Historical Annual Total Debt of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	215.18 Million ILS	1.13%
2022	212.77 Million ILS	27.55%
2021	166.81 Million ILS	8.15%
2020	154.23 Million ILS	-2.39%
2019	158.02 Million ILS	25305.31%
2018	622 Thousand ILS	-91.7%
2017	7.49 Million ILS	0.0%
2016	- ILS	0.0%
2015	- ILS	0.0%
2014	- ILS	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	206.81 Million ILS	-1.19%
2024 Q1	209.3 Million ILS	-2.73%
2023 Q3	203 Million ILS	-2.14%
2023 Q2	207.44 Million ILS	-1.48%
2023 Q1	210.55 Million ILS	-1.04%
2023 FY	215.18 Million ILS	1.13%
2023 Q4	215.18 Million ILS	6.0%
2022 Q4	212.77 Million ILS	-2.88%
2022 FY	212.77 Million ILS	27.55%
2022 Q2	209.03 Million ILS	-0.74%
2022 Q1	210.59 Million ILS	26.25%
2022 Q3	219.08 Million ILS	4.81%
2021 Q3	157.4 Million ILS	5.16%
2021 Q2	149.68 Million ILS	-0.36%
2021 FY	166.81 Million ILS	8.15%
2021 Q1	150.21 Million ILS	-2.61%
2021 Q4	166.81 Million ILS	5.98%
2020 Q1	156.65 Million ILS	-0.86%
2020 Q3	148.79 Million ILS	-2.44%
2020 Q2	152.51 Million ILS	-2.64%
2020 FY	154.23 Million ILS	-2.39%
2020 Q4	154.23 Million ILS	3.66%
2019 Q1	165.78 Million ILS	26553.7%
2019 FY	158.02 Million ILS	25305.31%
2019 Q4	158.02 Million ILS	-1.08%
2019 Q3	159.75 Million ILS	-2.93%
2019 Q2	164.58 Million ILS	-0.73%
2018 Q4	622 Thousand ILS	-2.2%
2018 FY	622 Thousand ILS	-91.7%
2018 Q1	7.06 Million ILS	-5.72%
2018 Q2	895 Thousand ILS	-87.34%
2018 Q3	636 Thousand ILS	-28.94%
2017 Q2	- ILS	0.0%
2017 Q1	- ILS	0.0%
2017 Q3	- ILS	0.0%
2017 Q4	7.49 Million ILS	0.0%
2017 FY	7.49 Million ILS	0.0%
2016 Q1	- ILS	0.0%
2016 FY	- ILS	0.0%
2016 Q4	- ILS	0.0%
2016 Q3	- ILS	0.0%
2015 Q4	- ILS	0.0%
2015 FY	- ILS	0.0%
2014 FY	- ILS	0.0%

Peer Total Debt Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Total Debt	Total Debt Difference